Trial Profile
An Open-Label, Single Dose Study Designed to Assess the Mass Balance Recovery, Metabolite Profiles and Metabolite Identification of [14C]-Estetrol in Healthy Female Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Estetrol (Primary)
- Indications Atrophic vaginitis; Breast cancer; Migraine; Osteoarthritis; Pregnancy; Vasomotor symptoms
- Focus Pharmacokinetics
- Sponsors Estetra SPRL
- 17 May 2016 Status changed from recruiting to completed.
- 29 Mar 2016 New trial record